Back to ASLMS 2020 Home

Guidelines for Review and Selection of Abstracts

Approved by ASLMS Board of Directors on July 24, 2017

1. All abstracts submitted to the Annual Conference will be evaluated by iThenticate (or similar software in an effort to verify the originality of the works. The software package is used to verify content has not been plagiarized and cross-references published matter against the submission.

1.1 Submissions with iThenticate scores of 40% or greater will be subject to review by the CME Director and Annual Conference Program Chair for the Annual Conference (abstracts) and the Editor-in-Chief for Lasers in Surgery and Medicine (manuscripts). Furthermore, the author will be sent a warning letter and will be requested to advise the appropriate parties as to how the material differs.

1.2 Submissions with iThenticate scores of 75% or greater will not be considered for presentation at the Annual Conference or publication, unless the author can demonstrate that the material submitted has not, in fact, been previously submitted for publication or published.

2. The CME Director will review iThenticate results, and provide feedback on those abstracts scoring 40% or greater as per item “a.” above. Abstracts that meet acceptable iThenticate criteria are then forwarded to the Program Chairpersons for the next review step.

3. 
The Program Chairperson(s) performs an initial review of all ASLMS Program abstract submissions that have been approved via the iThenticate process and CME Director review.  The Program Chairperson(s) may at his/her discretion, re-categorize the abstracts, suggest for ePoster, or suggest for rejection/editing. Any suggestions are then forwarded to the Section Chairperson(s) for the next level of review.

4. The Section Chairperson(s) performs a final review of all approved abstracts and makes a determination whether to accept, reject (with clear reasoning provided), suggest for ePoster, or suggest for a different category. The Section Chairperson(s) organizes accepted abstracts by common topics and creates a session schedule of selected abstracts for presentation at the Annual Conference.

** Note: If upon review, an abstract is suggested for a category other than the original category which the author submitted under, the author will be subsequently notified and allowed the first right of refusal for category change. The author will also be informed that if he/she declines the abstract category change, the abstract may not be accepted for the program or referred to ePoster.

Given the brevity of abstracts, the Program and Section Chairpersons realize that the detail level obtained through this process cannot achieve the level of a full article in a peer-reviewed journal. However, the spirit of this Annual Conference is that full disclosure (regarding conflicts of interest as well as details in methodology) will be expected and must be provided at the time of presentation. Abstracts that cannot meet these requirements due to intellectual property concerns, or withhold vital methodology specifics do not represent the spirit and intent of the Annual Conference and should not be submitted as they do not meet the criteria for acceptance.

PLEASE NOTE - ACCME regulations require that all presentations be created without the appearance of a conflict of interest and cannot contain any advertising, trade names, corporate logos, or product-group messages.

Criteria for Review

The Section Chairpersons also take into consideration the following criteria when reviewing abstracts:

  • Abstracts must not have been published or presented previously (clinical series updates are an exception to this stipulation).
  • ASLMS recognizes plagiarism, including self-plagiarism as a serious problem.  All abstracts submitted to the Annual Conference and all manuscripts submitted to Lasers in Surgery and Medicine will be submitted to evaluation by iThenticate (or similar) software in an effort to verify the originality of the works.  The software package is used to verify content has not been plagiarized and cross references published matter against the submission. 
  • ALL scientific research referred to, reported on, or used in the abstract must conform to the generally accepted standards of experimental design, data collection, and analysis.
  • Selection of abstracts for presentation will be limited to those abstracts that report already collected data. Abstracts must contain tangible factual information and should accurately reflect work that has actually been performed. Statements such as "results will be discussed' are unacceptable.
  • The number of patients in the study will be taken into consideration.  Scientific, well-designed studies are given preference over anecdotal findings or single experiment or case. With rare exception, abstracts that present a single or a small number of cases should not be accepted for paper presentation, but may be appropriate for ePoster consideration.
  • Abstracts must be of high quality and be presented with no bias toward a specific company(ies).
  • Recommendations in the abstract involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
  • The abstract must not present recommendations, treatment, or manners of practicing medicine that are not within the definitions as noted above, are known to have risks or dangers that outweigh the benefits, or are known to be ineffective in the treatment of patients.
  • Each author of an abstract submitted to ASLMS must have made a significant contribution to the research and must assume responsibility for the content of the abstract.
  • The number of abstracts submitted by an individual and/or institution will be taken into consideration. In order to provide diversity of input, we discourage any one author making more than two presentations in a session.  The other submissions could be submitted for the ePoster session.
  • The purpose of our conference is to disseminate accurate, balanced and objective information regarding lasers, other optical sources and related technologies in medicine and surgery.  This purpose is best served by including presentations that are varied in terms of topics and presenters. 
  • Abstracts should feature category-specific data with the expectation of full disclosure regarding methods and materials.
  • UPDATED: Full disclosure of Conflict of Interest (COI) is expected and required of ALL authors and co-authors prior to abstract consideration. Authors who do not submit disclosure by the required deadline will first be notified with request to submit immediately. If notified author does not comply, the presenting author has the discretion to either remove the non-complying author(s) name from the abstract or withdraw the abstract from consideration.

Additional Guidelines and Considerations for Scientific Abstracts

  • Clear research problem and/or translational potential based on scientific rational that is hypothesis driven.
  • Appropriate and clearly explained techniques with creative research or common techniques with a “novel issues and questions” approach.
  • Clearly described number of experiments/animals with clearly defined measures such as: use of controls, bioassays, behavioral tests, data analysis/statistical analysis procedures, specific device and/or treatment parameters, and other measures.
  • Clearly presented results with demonstrated significance presented as quantitative data with proper statistical information such as standard deviation (SD), standard error of mean (SEM), n- and p-values and the relationship of the hypothesis and the results addressed.
  • Conclusions should accurately reflect the results, address the hypothesis and are placed in a broader context with discussion of the translational potential of the research.

IMPORTANT NOTE: To start the submission process, click the button below. You will be re-directed to the log-in page. Once you log in, or create a new account if you do not already have a log-in, you will be directed to the abstract submission page.

SUBMIT ABSTRACT OR CASE STUDY

`